TP53 and lung cancer: Furthermore, a recent observational study by McGranahan et al.32 using publicly available TCGA database, indicated that most of the EGFR and TP53 somatic mutations in lung cancer are clonal and typically occur early in tumour evolution, likely even before tumorigenesis.